Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Promising preclinical results with Vertex's Aurora kinase inhibitor VX-680

March 1, 2004

Gabapentin found effective against tamoxifen-related hot flashes in breast cancer

March 1, 2004

Orphan drug designation for CG-53135

Feb. 27, 2004

Mitsui Chemicals claims telomerase inhibitors for cancer and other uses

Feb. 27, 2004

Neoprobe to meet FDA concerning RIGScan CR49 BLA

Feb. 27, 2004

Attenuon and Kirin Brewery enter antibody collaboration for cancer

Feb. 27, 2004

Good efficacy and safety profile found for R-115777 in MDS

Feb. 26, 2004

SuperGen acquires European marketing authorizations for Nipent

Feb. 26, 2004

New tubulin polymerization inhibitors covered by Zentaris patent

Feb. 26, 2004

AstraZeneca describes new MEK inhibitors with utility in solid tumor therapy

Feb. 26, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...